The global myocardial ischemia market size was worth around USD 4.62 billion in 2024 and is predicted to grow to around USD 8.20 billion by 2035 with a compound annual growth rate (CAGR) of 5.35 % from 2025 to 2035. The market for myocardial ischemia presents opportunities in wearable monitoring devices, AI-driven risk prediction, tailored medicines, less invasive treatments, better diagnostics, and growing awareness-driven healthcare initiatives in developing nations.